Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1998 Mar;91(3):118–126. doi: 10.1177/014107689809100302

Culture and medicine.

J Swales 1
PMCID: PMC1296558  PMID: 9659321

Full text

PDF
118

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asch D. A., Ubel P. A. Rationing by any other name. N Engl J Med. 1997 Jun 5;336(23):1668–1671. doi: 10.1056/NEJM199706053362309. [DOI] [PubMed] [Google Scholar]
  2. Clarke K. W., Gray D., Hampton J. R. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J. 1994 Jun;71(6):584–587. doi: 10.1136/hrt.71.6.584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cohn J. N., Bristow M. R., Chien K. R., Colucci W. S., Frazier O. H., Leinwand L. A., Lorell B. H., Moss A. J., Sonnenblick E. H., Walsh R. A. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation. 1997 Feb 18;95(4):766–770. doi: 10.1161/01.cir.95.4.766. [DOI] [PubMed] [Google Scholar]
  4. Garay R. P., Elghozi J. L., Dagher G., Meyer P. Laboratory distinction between essential and secondary hypertension by measurement of erythrocyte cation fluxes. N Engl J Med. 1980 Apr 3;302(14):769–771. doi: 10.1056/NEJM198004033021402. [DOI] [PubMed] [Google Scholar]
  5. Giardiello F. M., Brensinger J. D., Petersen G. M., Luce M. C., Hylind L. M., Bacon J. A., Booker S. V., Parker R. D., Hamilton S. R. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med. 1997 Mar 20;336(12):823–827. doi: 10.1056/NEJM199703203361202. [DOI] [PubMed] [Google Scholar]
  6. Howden-Chapman P., Carter J., Woods N. Blood money: blood donors' attitudes to changes in the New Zealand blood transfusion service. BMJ. 1996 May 4;312(7039):1131–1132. doi: 10.1136/bmj.312.7039.1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kleber F. X. The economics of cardiac failure. J R Soc Med. 1996 Jan;89(1):9–12. doi: 10.1177/014107689608900104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Maynard A. Evidence-based medicine: an incomplete method for informing treatment choices. Lancet. 1997 Jan 11;349(9045):126–128. doi: 10.1016/S0140-6736(96)05153-7. [DOI] [PubMed] [Google Scholar]
  9. McNeil B. J., Weichselbaum R., Pauker S. G. Fallacy of the five-year survival in lung cancer. N Engl J Med. 1978 Dec 21;299(25):1397–1401. doi: 10.1056/NEJM197812212992506. [DOI] [PubMed] [Google Scholar]
  10. Redelmeier D. A., Tversky A. Discrepancy between medical decisions for individual patients and for groups. N Engl J Med. 1990 Apr 19;322(16):1162–1164. doi: 10.1056/NEJM199004193221620. [DOI] [PubMed] [Google Scholar]
  11. Sackett D. L. Zlinkoff honor lecture: basic research, clinical research, clinical epidemiology, and general internal medicine. J Gen Intern Med. 1987 Jan-Feb;2(1):40–47. doi: 10.1007/BF02596250. [DOI] [PubMed] [Google Scholar]
  12. Sweeney K. G., Gray D. P., Steele R., Evans P. Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice. Br J Gen Pract. 1995 Mar;45(392):153–158. [PMC free article] [PubMed] [Google Scholar]
  13. Ubel P. A., DeKay M. L., Baron J., Asch D. A. Cost-effectiveness analysis in a setting of budget constraints--is it equitable? N Engl J Med. 1996 May 2;334(18):1174–1177. doi: 10.1056/NEJM199605023341807. [DOI] [PubMed] [Google Scholar]
  14. Ul Haq I., Ramsay L. E., Pickin D. M., Yeo W. W., Jackson P. R., Payne J. N. Lipid-lowering for prevention of coronary heart disease: what policy now? Clin Sci (Lond) 1996 Oct;91(4):399–413. doi: 10.1042/cs0910399. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES